Replies to post #12994 on Regen BioPharma Inc (RGBP)

[Canadian Trader]

Thanks NEW, this is actually an abstract book for the 13th International Symposium on Myelodysplastic Syndromes being held April 29 - May 2, 2015. Regen will present two oral presentations and one poster presentation, as per the April 7th RGBP PR:

http://www.marketwired.com/press-release/regen-biopharma-inc-present-multiple-presentations-13th-international-symposium-on-myelodysplastic-otcbb-rgbp-2007259.htm


The abstracts have been published in Elsevier’s journal Leukemia Research. Bottom line - more eyes to see them!

Symposium website: http://mds.kenes.com/

----------

Poster Presentation Abstract: T.Ichim - HEMAXELLERATE I™, AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION CELLS, FOR SEVERE APLASTIC ANEMIA
30-Apr-2015 08:30 16:30
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112483513

Oral Presentation 1 Abstract: C.Ichim - TECHNIQUE FOR ESTABLISHMENT OF LONG TERM IN VITRO CULTURES OF PRIMARY MDS CELLS
30-Apr-2015 14:00 15:30
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112483497

Oral Presentation 2 Abstract: C.Ichim - NR2F6 (EAR-2) IS A NOVEL LEUKEMIA AND MDS ONCOGENE, OVER-EXPRESSED IN PATIENTS, THAT INHIBITS HEMATOPOIETIC DIFFERENTIATION AND BLOCKS ERYTHROPOIETIC DIFFERENTIATION AT THE PROERYTHROCYTE STAGE
01-May-2015 11:00 12:00
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112483492

$ RGBP $